We are live on
!
Find out more
KA
Kozak & Associates Portfolio holdings
AUM
$576M
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+12.15%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
–
AUM
$248M
AUM Growth
+$25.2M
(+11%)
Cap. Flow
-$355K
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
76.44%
Holding
367
New
28
Increased
133
Reduced
23
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Tech Independence Focused ETF
IETC
|
+$348K |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$337K |
| 3 |
iShares US Financial Services ETF
IYG
|
+$239K |
| 4 |
Apple
AAPL
|
+$207K |
| 5 |
Deere & Co
DE
|
+$195K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$605K |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$421K |
| 3 |
Idexx Laboratories
IDXX
|
+$400K |
| 4 |
Agilent Technologies
A
|
+$319K |
| 5 |
Baidu
BIDU
|
+$178K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.19% |
| 2 | Consumer Discretionary | 4.63% |
| 3 | Financials | 4.62% |
| 4 | Consumer Staples | 2.47% |
| 5 | Industrials | 2.43% |
Similar funds
SCM
EIP
GAM
MIOT
PG
WCCM
BL
IDA
Kozak & Associates's Q2 2023 Portfolio in Review
As of Q2 2023, Kozak & Associates held 367 positions worth $248M, up 11% from $223M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Kozak & Associates's Q2 2023 filing shows 28 new, 133 increased, 23 reduced and 10 closed positions. Its largest new stake was iShares Core Universal USD Bond ETF: 536 shares worth $24.2K. The largest sale was Thermo Fisher Scientific, an estimated $605K.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
- Kozak & Associates's largest Q2 2023 buy was iShares Core Universal USD Bond ETF: 536 shares worth $24.2K.
- Kozak & Associates added most to iShares US Tech Independence Focused ETF in Q2 2023, an estimated $348K increase.
- Kozak & Associates's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $421K.
- Kozak & Associates fully exited Thermo Fisher Scientific in Q2 2023, selling an estimated $605K.
- Kozak & Associates's ten largest holdings make up 76% of its $248M portfolio in Q2 2023.
- Kozak & Associates opened 28 new positions and closed 10 in Q2 2023.
- Kozak & Associates's portfolio value rose 11% quarter-over-quarter to $248M.
Based on Kozak & Associates's 13F filing for Q2 2023, filed 5 Jul 2023.